{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:47Z","timestamp":1793600867596,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabres.2026.113211","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:02:46Z","timestamp":1773457366000},"page":"113211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of angiopoietin-like 4 (ANGPTL4) protein and O-linked \u03b2-N-acetylglucosamine(O-GlcNAc) in diabetic nephropathy"],"prefix":"10.1016","volume":"235","author":[{"given":"Abhishek","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Badruddeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Irfan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.diabres.2026.113211_b0005","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.5958\/0974-360X.2019.00816.3","article-title":"Regulatory mechanism of caffeic acid on glucose metabolism in diabetes","volume":"12","author":"Yusuf","year":"2019","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.diabres.2026.113211_b0010","doi-asserted-by":"crossref","unstructured":"Ambreen Shoaib, Salem-Bekhit Mounir M., Siddiqui Hefazat H, Dixit Rakesh K, Mohsen Bayomi, Khalid Mohammad, et al. Antidiabetic activity ofstandardized dried tubers extract ofAconitum napellus instreptozotocin\u2010induced diabetic rats. 3 Biotech 2020; 10: 56. doi: 10.1007\/s13205-019-2043-7.","DOI":"10.1007\/s13205-019-2043-7"},{"issue":"10397","key":"10.1016\/j.diabres.2026.113211_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Gbd","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.diabres.2026.113211_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108357","article-title":"Present and future directions in diabetic kidney disease","volume":"36","author":"Limonte","year":"2022","journal-title":"J Diabetes Compl"},{"issue":"Supplement 1","key":"10.1016\/j.diabres.2026.113211_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113211_b0030","unstructured":"Murdeshwar HN, Anjum F. Hemodialysis. In: StatPearls. Edn. Treasure Island (FL) Ineligible Companies. Disclosure: Fatima Anjum Declares no Relevant Financial Relationships with Ineligible Companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC. 2024."},{"key":"10.1016\/j.diabres.2026.113211_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0040","doi-asserted-by":"crossref","first-page":"95410","DOI":"10.5527\/wjn.v13.i2.95410","article-title":"Unleashing the pathological role of epithelial-to- mesenchymal transition in diabetic nephropathy: the intricate connection with multifaceted mechanism","volume":"13","author":"Balakumar","year":"2024","journal-title":"World J Nephrol"},{"issue":"5","key":"10.1016\/j.diabres.2026.113211_b0045","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41401-024-01228-5","article-title":"tRF3-IleAAT reduced extracellular matrix synthesis in diabetic kidney disease mice by targeting ZNF281 and inhibiting ferroptosis","volume":"45","author":"Qiao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.diabres.2026.113211_b0050","article-title":"Application and design considerations of ROS-based nanomaterials in diabetic kidney disease","volume":"15","author":"Huang","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113211_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113211_b0060","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2147\/DMSO.S450695","article-title":"Autophagy, pyroptosis and ferroptosis are rising stars in the pathogenesis of diabetic nephropathy","volume":"17","author":"Li","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13098-024-01393-x","article-title":"RUNX3-activated apelin signaling inhibits cell proliferation and fibrosis in diabetic nephropathy by regulation of the SIRT1\/FOXO pathway","volume":"16","author":"Zhong","year":"2024","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"10.1016\/j.diabres.2026.113211_b0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/biom14060733","article-title":"Roles of mitochondrial dysfunction in diabetic kidney disease: new perspectives from mechanism to therapy","volume":"14","author":"Yang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.diabres.2026.113211_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.vh.2024.02.007","article-title":"Advanced glycation end products and insulin resistance in diabetic nephropathy","volume":"125","author":"Parwani","year":"2024","journal-title":"Vitam Horm"},{"issue":"1\u20133","key":"10.1016\/j.diabres.2026.113211_b0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejphar.2007.10.070","article-title":"Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats","volume":"579","author":"Kang","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.diabres.2026.113211_b0085","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/ndt\/gfs121","article-title":"Cellular and molecular mechanisms of diabetic glomerulopathy","volume":"27","author":"Gnudi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.diabres.2026.113211_b0090","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.freeradbiomed.2007.12.005","article-title":"Acute hyperglycemia and oxidative stress: direct cause and effect?","volume":"44","author":"Choi","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.diabres.2026.113211_b0095","first-page":"317","article-title":"Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review","volume":"142","author":"Rodrigo","year":"2006","journal-title":"Comp Biochem Physiol C: Toxicol Pharmacol"},{"issue":"05","key":"10.1016\/j.diabres.2026.113211_b0100","first-page":"247","article-title":"Receptor for advanced glycation end products: dementia and cognitive impairment","volume":"73","author":"Singh","year":"2023","journal-title":"Georg Thieme Verlag Publ"},{"key":"10.1016\/j.diabres.2026.113211_b0110","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI119853","article-title":"Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy","volume":"100","author":"Witztum","year":"1997","journal-title":"J Clin Invest"},{"issue":"2022","key":"10.1016\/j.diabres.2026.113211_b0115","article-title":"Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments","volume":"307","author":"Wasim","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2026.113211_b0120","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1097\/01.ASN.0000077407.90309.65","article-title":"PKC-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase","volume":"14","author":"Inoguchi","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113211_b0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"Kanwar","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.diabres.2026.113211_b0145","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s001250051076","article-title":"Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes","volume":"41","author":"Sano","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113211_b0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s001250050900","article-title":"Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells mediated by reactive oxygen species","volume":"41","author":"Du","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113211_b0160","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor b is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.diabres.2026.113211_b0165","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113211_b0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrology"},{"key":"10.1016\/j.diabres.2026.113211_b0175","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1681\/ASN.2004110961","article-title":"Acute-phase markers of inflammation and glomerular structure in patients with type 2diabetes","volume":"16","author":"Dalla Vestra","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113211_b0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.V93433","article-title":"TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide","volume":"9","author":"McCarthy","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113211_b0260","doi-asserted-by":"crossref","unstructured":"Wang Y, Li K, Yuan S, Yu C, Yin R, Wang D, Xu Y, Zhang L, Wei L, Cheng Y, Mao L, Zhao D, Yang L. Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type\u20092 diabetes patients. J Diabetes Investig. 2024 Dec;15(12):1763-1772. doi: 10.1111\/jdi.14304. Epub 2024 Sep 12. PMID: 39264678; PMCID: PMC11615698.","DOI":"10.1111\/jdi.14304"},{"key":"10.1016\/j.diabres.2026.113211_b0265","doi-asserted-by":"crossref","unstructured":"Srivastava SP, Zhou H, Shenoi R, Morris M, Lainez-Mas B, Goedeke L, et al. Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease. Sci Adv. 2024 Dec 6;10(49):eadn6068. doi: 10.1126\/sciadv.adn6068. Epub 2024 Dec 4. PMID: 39630889; PMCID: PMC11616692.","DOI":"10.1126\/sciadv.adn6068"},{"issue":"9","key":"10.1016\/j.diabres.2026.113211_b0440","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/ndt\/gfw463","article-title":"O-linked \u03b2-N- acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes","volume":"32","author":"Ono","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.diabres.2026.113211_b0445","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","article-title":"Partial epithelial-to- mesenchymal transition and other new mechanisms of kidney fibrosis","volume":"27","author":"Lovisa","year":"2016","journal-title":"Trends Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41419-021-03643-6","article-title":"Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria","volume":"12","author":"Nishad","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.diabres.2026.113211_b0105","article-title":"Role of rosiglitazone in experimental Wistar rats model of neurodegeneration: effect of peroxisome proliferator-activated receptors-\u03b3 as advanced glycation end products receptor of advanced glycation end products axis inhibitor","author":"Naz","year":"2025","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.diabres.2026.113211_b0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2362.2004.01429.x","article-title":"New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology","volume":"34","author":"Wolf","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113211_b0135","doi-asserted-by":"crossref","first-page":"F1622","DOI":"10.1152\/ajprenal.00078.2009","article-title":"Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells","volume":"297","author":"Wu","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0140","article-title":"An outlook on pathological pathways of diabetes and molecular mechanisms of anti-diabetic phytobioactives","volume":"1","author":"Anwar","year":"2024","journal-title":"Bentham Sci Publ"},{"issue":"72","key":"10.1016\/j.diabres.2026.113211_b0150","first-page":"496","article-title":"Neurodegeneration: microglia: Nf-Kappab signaling pathways","volume":"2022","author":"Singh","year":"2022","journal-title":"Thieme Drug Res"},{"key":"10.1016\/j.diabres.2026.113211_b0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2026.113211_b0190","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1074\/jbc.M307583200","article-title":"Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4","volume":"279","author":"Ge","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113211_b0195","doi-asserted-by":"crossref","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","article-title":"Protepro-inflammatoryng of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity","volume":"286","author":"Lei","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113211_b0200","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113211_b0205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids","volume":"29","author":"Kersten","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2026.113211_b0210","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/01.wnr.0000224776.12647.ba","article-title":"Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic\/ischaemic mouse brain","volume":"17","author":"Wiesner","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.diabres.2026.113211_b0215","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/db10-0145","article-title":"Hypothalamic ANGPTL4\/FIAF is a novel regulator of food intake and body weight","volume":"59","author":"Kim","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113211_b0220","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene","volume":"275","author":"Kersten","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113211_b0225","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1074\/jbc.M809802200","article-title":"A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization","volume":"284","author":"Yau","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113211_b0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/db07-1438","article-title":"Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans","volume":"58","author":"Staiger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113211_b0235","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.0408452102","article-title":"Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice","volume":"102","author":"Xu","year":"2005","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.diabres.2026.113211_b0240","first-page":"23","article-title":"Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease","volume":"25","author":"Chugh","year":"2014","journal-title":"Front Pharmacol"},{"issue":"505","key":"10.1016\/j.diabres.2026.113211_b0500","article-title":"Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via \u03b21 Integrin\/FAK signaling in diabetic nephropathy","volume":"5","author":"Guo","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"19","key":"10.1016\/j.diabres.2026.113211_b0285","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.3390\/ijms231911260","article-title":"O-GlcNAcylation in renal (Patho)physiology","volume":"23","author":"Silva-Aguiar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113211_b0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nm0111-44","article-title":"Filtering new facts about kidney disease","volume":"17","author":"Reiser","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2026.113211_b0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2026.113211_b0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating Angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/j.diabres.2026.113211_b0270","article-title":"Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target","volume":"7","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2026.113211_b0275","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.diabres.2026.113211_b0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.O112.018366","article-title":"Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse","volume":"11","author":"Trinidad","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.diabres.2026.113211_b0290","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fendo.2018.00415","article-title":"O-GlcNAc: a sweetheart of the cell cycle and DNA damage response","volume":"9","author":"Liu","year":"2018","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0300","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/ijms20020404","article-title":"The role of O-GlcNAcylation for protection against ischemia-reperfusion injury","volume":"20","author":"Jensen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113211_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111477","article-title":"Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation","volume":"138","author":"Cong","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12929-020-00648-9","article-title":"O-GlcNAcylation and its role in the immune system","volume":"27","author":"Chang","year":"2020","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0315","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/08923973.2022.2128370","article-title":"Pre-clinical investigation of protective effect of nutraceutical D-glucosamine on TNBS-induced colitis","volume":"45","author":"Roy","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113211_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165556","article-title":"O-GlcNAcylation of RAF1 increases its stabilization and induces the renal fibrosis","volume":"1866","author":"Feng","year":"2020","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105616","article-title":"Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals","volume":"300","author":"Liu","year":"2024","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0330","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00851-w","article-title":"Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models","volume":"29","author":"Issad","year":"2022","journal-title":"J Biomed Sci"},{"issue":"35","key":"10.1016\/j.diabres.2026.113211_b0335","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8092","article-title":"Ventromedial hypothalamic OGT drives adipose tissue lipolysis and curbs obesity","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.diabres.2026.113211_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2021.105320","article-title":"O-GlcNAc cycling mediates energy balance by regulating caloric memory","volume":"165","author":"Andersson","year":"2021","journal-title":"Appetite"},{"issue":"11","key":"10.1016\/j.diabres.2026.113211_b0345","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","article-title":"O-GlcNAcylation in health and neurodegenerative diseases","volume":"53","author":"Lee","year":"2021","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113211_b0350","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41380-025-02943-z","article-title":"Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications","volume":"30","author":"Chen","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.diabres.2026.113211_b0355","article-title":"Role of O-GlcNAcylation in Alzheimer\u2019s disease: Insights and perspectives","volume":"12","author":"Sharma","year":"2024","journal-title":"Euro J Med Chem Rep"},{"issue":"10","key":"10.1016\/j.diabres.2026.113211_b0360","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/s41380-022-01689-2","article-title":"SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy","volume":"27","author":"Yin","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.diabres.2026.113211_b0365","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3233\/JAD-230955","article-title":"O-GlcNAcylation and its roles in neurodegenerative diseases","volume":"97","author":"Du","year":"2024","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"12","key":"10.1016\/j.diabres.2026.113211_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105411","article-title":"Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases","volume":"299","author":"Pratt","year":"2023","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06670-1","article-title":"Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson\u2019s disease pathology","volume":"15","author":"Kim","year":"2024","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.diabres.2026.113211_b0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3207","article-title":"O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer\u2019s disease by inhibiting necroptosis","volume":"7","author":"Park","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.diabres.2026.113211_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1387931","article-title":"O-GlcNAc impacts mitophagy via the PINK1-dependent pathway","volume":"16","author":"Alghusen","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.diabres.2026.113211_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107160","article-title":"O-GlcNAc cycling in neuroinflammation: from molecular mechanisms and therapeutic perspectives","volume":"217","author":"Lee","year":"2025","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.diabres.2026.113211_b0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41419-024-06773-9","article-title":"O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts","volume":"15","author":"Very","year":"2024","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0400","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbrc.2010.10.113","article-title":"The role of O-linked GlcNAc modification on the glucose response of ChREBP","volume":"402","author":"Sakiyama","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2026.113211_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607080","article-title":"O-GlcNAcylation suppresses the ion current IClswell by preventing the binding of the protein ICln to \u03b1-integrin","volume":"8","author":"Costa","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.diabres.2026.113211_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121070","article-title":"What does not kill mesangial cells makes it stronger? the response of the endoplasmic reticulum stress and the O-GlcNAc signaling to ATP depletion","volume":"311","author":"Silva","year":"2022","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0415","doi-asserted-by":"crossref","first-page":"E713","DOI":"10.1152\/ajpendo.00108.2011","article-title":"O-linked\u03b2-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells","volume":"301","author":"Goldberg","year":"2011","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.diabres.2026.113211_b0420","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2337\/diabetes.51.10.3083","article-title":"Podocyte number in normotensive type diabetic patients with albuminuria","volume":"51","author":"White","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.diabres.2026.113211_b0425","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.17219\/acem\/104534","article-title":"Glomerular podocytes in diabetic renal disease","volume":"28","author":"Podg\u00f3rski","year":"2019","journal-title":"Adv Clin Exp Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113211_b0430","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/db25-0484","article-title":"O-GlcNAcylation stabilizes NEK7 to drive podocyte pyroptosis in diabetic kidney disease","volume":"74","author":"Chen","year":"2025","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2026.113211_b0435","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/dom.16274","article-title":"Multiomics analysis of O\u2010GlcNAcylation in podocytes of diabetic kidney disease","volume":"27","author":"Zou","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113211_b0455","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15436","article-title":"O-linked \u03b2-N-acetylglucosamine(O-GluNAc) modification: emerging pathogenesis and a therapeutic target of diabetic nephropathy","volume":"42","author":"Qi","year":"2025","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0460","doi-asserted-by":"crossref","first-page":"17599","DOI":"10.1038\/s41598-023-44177-5","article-title":"Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic \u03b2-cell dysfunction and reducing kidney EMT","volume":"13","author":"Cho","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1620\/tjem.2023.J015","article-title":"Polysaccharide H-1-2 ameliorates high glucose-induced Podocyte dysfunction by suppressing epithelial-to-mesenchymal transition via restoration of SIRT1 in vivo and in vitro","volume":"260","author":"Li","year":"2023","journal-title":"Tohoku J Exp Med"},{"issue":"33","key":"10.1016\/j.diabres.2026.113211_b0470","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1074\/jbc.RA118.001746","article-title":"O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats","volume":"293","author":"Silva-Aguiar","year":"2018","journal-title":"J Biol Chem"},{"issue":"29","key":"10.1016\/j.diabres.2026.113211_b0475","doi-asserted-by":"crossref","first-page":"30133","DOI":"10.1074\/jbc.M403773200","article-title":"Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. a survival response of mammalian cells","volume":"279","author":"Zachara","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0480","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjms.2019.11.010","article-title":"TGF-\u03b2 and diabetic nephropathy: lessons learned over the past 20 years","volume":"359","author":"Gewin","year":"2020","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0485","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm9020458","article-title":"Inflammatory targets in diabetic nephropathy","volume":"9","author":"Donate-Correa","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2026.113211_b0490","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1038\/s41467-025-61022-7","article-title":"O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis","volume":"16","author":"Ahmed","year":"2025","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.diabres.2026.113211_b0495","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biochi.2008.03.005","article-title":"O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?","volume":"90","author":"Kuo","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.diabres.2026.113211_b0505","doi-asserted-by":"crossref","unstructured":"Housley MP, Rodgers JT, Udeshi ND, Kelly TJ, Shabanowitz J, Hunt DF, Puigserver P, Hart GW. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem. 2008 Jun 13;283(24):16283-92. doi: 10.1074\/jbc.M802240200. Epub 2008 Apr 17. PMID: 18420577; PMCID: PMC2423255.","DOI":"10.1074\/jbc.M802240200"},{"issue":"45","key":"10.1016\/j.diabres.2026.113211_b0510","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.0806198105","article-title":"NF\u03baB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions","volume":"105","author":"Yang","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.diabres.2026.113211_b0515","doi-asserted-by":"crossref","unstructured":"Ramakrishnan P, Clark PM, Mason DE, Peters EC, Hsieh-Wilson LC, Baltimore D. Activation of the transcriptional function of the NF-\u03baB protein c-Rel by O-GlcNAc glycosylation. Science signaling. 2013 Aug 27;6(290):ra75-.","DOI":"10.1126\/scisignal.2004097"},{"issue":"14","key":"10.1016\/j.diabres.2026.113211_b0520","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor \u03b3 target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113211_b0525","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s12967-024-05466-3","article-title":"The ANGPTL4-HIF-1\u03b1 loop: a critical regulator of renal interstitial fibrosis","volume":"22","author":"Li","year":"2024","journal-title":"J Transl Med"},{"issue":"38","key":"10.1016\/j.diabres.2026.113211_b0530","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","article-title":"Angiopoietin-like 4 (ANGPTL4\/FIAF) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism","volume":"284","author":"Koliwad","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0535","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-014-0486-5","article-title":"Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy","volume":"49","author":"Ma","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.diabres.2026.113211_b0540","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.gendis.2020.07.005","article-title":"Lipopolysaccharide-induced podocyte injury is regulated by calcineurin\/NFAT and TLR4\/MyD88\/NF-\u03baB signaling pathways through angiopoietin-like protein 4","volume":"9","author":"Shen","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.diabres.2026.113211_b0545","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13098-025-01726-4","article-title":"Decoding diabetic kidney disease: a comprehensive review of interconnected pathways, molecular mediators, and therapeutic insights","volume":"17","author":"Efiong","year":"2025","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.diabres.2026.113211_b0550","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14789450.2013.820536","article-title":"Protein O-GlcNAcylation in diabetes and diabetic complications","volume":"10","author":"Ma","year":"2013","journal-title":"Exp Rev Proteom"},{"key":"10.1016\/j.diabres.2026.113211_b0555","doi-asserted-by":"crossref","unstructured":"Zuo Y, He Z, Chen Y, Dai L. Dual role of ANGPTL4 in inflammation. Inflamm Res. 2023 Jun;72(6):1303-1313. doi: 10.1007\/s00011-023-01753-9. Epub 2023 Jun 10. PMID: 37300585; PMCID: PMC10256975.","DOI":"10.1007\/s00011-023-01753-9"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:41:07Z","timestamp":1793598067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726001300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":111,"alternative-id":["S0168822726001300"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113211","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of angiopoietin-like 4 (ANGPTL4) protein and O-linked \u03b2-N-acetylglucosamine(O-GlcNAc) in diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113211"}}